KRRO Q1 2026 Earnings EPS Beat Driven by Expense Management Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development SEB Q1 2026 Earnings Robust EPS Despite Limited Transparency BELFA Q1 2026 Earnings EPS Surpasses Estimates Stock Rises on Strong Performance NMTC Q1 2026 Earnings EPS Misses Estimates Stock Declines as Company Continues Development Phase VRCA Q1 2026 Earnings EPS Misses Estimates as Company Advances Pipeline